142 related articles for article (PubMed ID: 31659102)
1. Regulation of
Koh I; Nosaka S; Sekine M; Sugimoto J; Hirata E; Kudo Y
Cancer Genomics Proteomics; 2019; 16(6):481-490. PubMed ID: 31659102
[TBL] [Abstract][Full Text] [Related]
2. Regulation of multidrug resistance 1 expression by CDX2 in ovarian mucinous adenocarcinoma.
Koh I; Hinoi T; Sentani K; Hirata E; Nosaka S; Niitsu H; Miguchi M; Adachi T; Yasui W; Ohdan H; Kudo Y
Cancer Med; 2016 Jul; 5(7):1546-55. PubMed ID: 27060927
[TBL] [Abstract][Full Text] [Related]
3. Expression of REG4 in ovarian mucinous tumors.
Huang Q; Chen X; Lu W; Lai M; Lu B
Appl Immunohistochem Mol Morphol; 2014 Apr; 22(4):295-301. PubMed ID: 23958547
[TBL] [Abstract][Full Text] [Related]
4. Reg IV is a direct target of intestinal transcriptional factor CDX2 in gastric cancer.
Naito Y; Oue N; Hinoi T; Sakamoto N; Sentani K; Ohdan H; Yanagihara K; Sasaki H; Yasui W
PLoS One; 2012; 7(11):e47545. PubMed ID: 23133598
[TBL] [Abstract][Full Text] [Related]
5. Regenerating Family Member 4 (Reg4) Enhances 5-Fluorouracil Resistance of Gastric Cancer Through Activating MAPK/Erk/Bim Signaling Pathway.
Jin J; Lv H; Wu J; Li D; Chen K; Zhang F; Han J; Feng J; Zhang N; Yu H; Su D; Ying L
Med Sci Monit; 2017 Jul; 23():3715-3721. PubMed ID: 28759561
[TBL] [Abstract][Full Text] [Related]
6. CDX2 controls genes involved in the metabolism of 5-fluorouracil and is associated with reduced efficacy of chemotherapy in colorectal cancer.
Delhorme JB; Bersuder E; Terciolo C; Vlami O; Chenard MP; Martin E; Rohr S; Brigand C; Duluc I; Freund JN; Gross I
Biomed Pharmacother; 2022 Mar; 147():112630. PubMed ID: 35051860
[TBL] [Abstract][Full Text] [Related]
7. Combination chemotherapy of oxaliplatin and 5-fluorouracil may be an effective regimen for mucinous adenocarcinoma of the ovary: a potential treatment strategy.
Sato S; Itamochi H; Kigawa J; Oishi T; Shimada M; Sato S; Naniwa J; Uegaki K; Nonaka M; Terakawa N
Cancer Sci; 2009 Mar; 100(3):546-51. PubMed ID: 19154404
[TBL] [Abstract][Full Text] [Related]
8. REG4 Is Highly Expressed in Mucinous Ovarian Cancer: A Potential Novel Serum Biomarker.
Lehtinen L; Vesterkvist P; Roering P; Korpela T; Hattara L; Kaipio K; Mpindi JP; Hynninen J; Auranen A; Davidson B; Haglund C; Iljin K; Grenman S; Siitari H; Carpen O
PLoS One; 2016; 11(3):e0151590. PubMed ID: 26981633
[TBL] [Abstract][Full Text] [Related]
9. Musashi-2 is a novel regulator of paclitaxel sensitivity in ovarian cancer cells.
Lee J; An S; Choi YM; Lee J; Ahn KJ; Lee JH; Kim TJ; An IS; Bae S
Int J Oncol; 2016 Nov; 49(5):1945-1952. PubMed ID: 27600258
[TBL] [Abstract][Full Text] [Related]
10. CDX2 immunoreactivity in primary and metastatic ovarian mucinous tumours.
Fraggetta F; Pelosi G; Cafici A; Scollo P; Nuciforo P; Viale G
Virchows Arch; 2003 Dec; 443(6):782-6. PubMed ID: 14576939
[TBL] [Abstract][Full Text] [Related]
11. PAX2, PAX8 and CDX2 Expression in Metastatic Mucinous, Primary Ovarian Mucinous and Seromucinous Tumors and Review of the Literature.
Ates Ozdemir D; Usubutun A
Pathol Oncol Res; 2016 Jul; 22(3):593-9. PubMed ID: 26797858
[TBL] [Abstract][Full Text] [Related]
12. Up-regulation of cadherin 17 and down-regulation of homeodomain protein CDX2 correlate with tumor progression and unfavorable prognosis in epithelial ovarian cancer.
Huang LP; Yu YH; Sheng C; Wang SH
Int J Gynecol Cancer; 2012 Sep; 22(7):1170-6. PubMed ID: 22810971
[TBL] [Abstract][Full Text] [Related]
13. [Expression of the cdx2 gene in benign intestinal-type mucinous ovarian tumors].
Gaggero G; Sola S; Mora M; Fulcheri E
Pathologica; 2003 Aug; 95(4):185-91. PubMed ID: 14577202
[TBL] [Abstract][Full Text] [Related]
14. Reg IV, a new member of the regenerating gene family, is overexpressed in colorectal carcinomas.
Violette S; Festor E; Pandrea-Vasile I; Mitchell V; Adida C; Dussaulx E; Lacorte JM; Chambaz J; Lacasa M; Lesuffleur T
Int J Cancer; 2003 Jan; 103(2):185-93. PubMed ID: 12455032
[TBL] [Abstract][Full Text] [Related]
15. The role of the REG4 gene and its encoding product in ovarian epithelial carcinoma.
Chen S; Gou WF; Zhao S; Niu ZF; Zhao Y; Takano Y; Zheng HC
BMC Cancer; 2015 Jun; 15():471. PubMed ID: 26077911
[TBL] [Abstract][Full Text] [Related]
16. Single-chain Antibody Against Reg4 Suppresses Gastric Cancer Cell Growth and Enhances 5-FU-induced Cell Death in vitro.
Zhang XQ; Yu LT; Du P; Yin TQ; Zhang ZY; Xu Y; Li X; Li YJ; Wang M; Luo C
Anticancer Agents Med Chem; 2019; 19(5):610-619. PubMed ID: 30465515
[TBL] [Abstract][Full Text] [Related]
17. CDX2 and Reg IV expression and correlation in gastric cancer.
Chai D; Du H; Li K; Zhang X; Li X; Zhao X; Lian X; Xu Y
BMC Gastroenterol; 2021 Feb; 21(1):92. PubMed ID: 33639844
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemistry in the Diagnosis of Mucinous Neoplasms Involving the Ovary: The Added Value of SATB2 and Biomarker Discovery Through Protein Expression Database Mining.
Strickland S; Wasserman JK; Giassi A; Djordjevic B; Parra-Herran C
Int J Gynecol Pathol; 2016 May; 35(3):191-208. PubMed ID: 26535987
[TBL] [Abstract][Full Text] [Related]
19. CK7, CK20, CDX2 and MUC2 Immunohistochemical staining used to distinguish metastatic colorectal carcinoma involving ovary from primary ovarian mucinous adenocarcinoma.
Shin JH; Bae JH; Lee A; Jung CK; Yim HW; Park JS; Lee KY
Jpn J Clin Oncol; 2010 Mar; 40(3):208-13. PubMed ID: 19926591
[TBL] [Abstract][Full Text] [Related]
20. Ovarian mucinous tumors associated with mature cystic teratomas: morphologic and immunohistochemical analysis identifies a subset of potential teratomatous origin that shares features of lower gastrointestinal tract mucinous tumors more commonly encountered as secondary tumors in the ovary.
Vang R; Gown AM; Zhao C; Barry TS; Isacson C; Richardson MS; Ronnett BM
Am J Surg Pathol; 2007 Jun; 31(6):854-69. PubMed ID: 17527072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
